Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells

Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells

Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently, chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor growth by apoptosis induction. However, defects in apoptotic cellular responses frequently lead to drug resistance, which is t...

Full description

Bibliographic Details
Main Authors:	Marina Montagnani Marelli, Giangiacomo Beretta, Roberta Manuela Moretti
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	necroptosis delta-tocotrienol prostate cancer docetaxel chemoresistance
Online Access:	https://www.mdpi.com/1422-0067/24/5/4923

Similar Items

Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods
by: Elena Pudova, et al.
Published: (2023-12-01)

Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
by: Stephen A. Shrum, et al.
Published: (2023-11-01)

Immunoregulation of microglia with tocotrienols
by: Tan, Shi Wei
Published: (2012)

Tocotrienols : vitamin E beyond tocopherols /
by: Tan, Barrie, et al.
Published: (2013)

Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies
by: Mehrdad Hashemi, et al.
Published: (2023-04-01)

Tocotrienols as an Anti-Breast Cancer Agent
by: Madison Trujillo, et al.
Published: (2021-08-01)

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
by: Victor Omoboyede, et al.
Published: (2023-04-01)

Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
by: Hui-Li Wong, et al.
Published: (2015-06-01)

Immunomodulatory effects of palm oil-derived delta-tocotrienol on microglia responses
by: Tan, Shi Wei
Published: (2017)

MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B
by: Lina Liu, et al.
Published: (2023-09-01)

Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential
by: Giovanni Luca Beretta, et al.
Published: (2022-04-01)

Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines
by: Dinah Linke, et al.
Published: (2022-12-01)

Properties of alginate-chitosan microcapsule containing tocotrienols in self-assembled pickering emulsion and its stability in yogurt
by: Tan, Phui Yee
Published: (2017)

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
by: Lijuan Bai, et al.
Published: (2023-08-01)

Design and optimization of tocotrienol rich fraction nanoemulsion system for cosmeceutical application
by: Azizul Hasan, Zafarizal Aldrin
Published: (2018)

Eggmanone Effectively Overcomes Prostate Cancer Cell Chemoresistance
by: Chen Xie, et al.
Published: (2021-05-01)

Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells
by: Evelyn S. Sanchez-Hernandez, et al.
Published: (2023-08-01)

Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis
by: Sascha D. Markowitsch, et al.
Published: (2021-02-01)

Beta-Tocotrienol Exhibits More Cytotoxic Effects than Gamma-Tocotrienol on Breast Cancer Cells by Promoting Apoptosis via a P53-Independent PI3-Kinase Dependent Pathway
by: Maya Idriss, et al.
Published: (2020-04-01)

Tocotrienols: Dietary Supplements for Chronic Obstructive Pulmonary Disease
by: Xiangming Ji, et al.
Published: (2021-05-01)

Successful use of docetaxel for emergency treatment of disseminated intravascular coagulation due to hormone-refractory metastatic prostate cancer
by: Serkan Keskin, et al.
Published: (2017-07-01)

Combination of Kaempferol and Docetaxel Induces Autophagy in Prostate Cancer Cells In Vitro and In Vivo
by: Qian Zhou, et al.
Published: (2023-09-01)

Efficacy of epidermal growth factor tocotrienol rich fraction cream formulation in deep-partial thickness burn in Sprague-Dawley rats
by: Ahmad Zaini, Asma
Published: (2018)

Protective Effects of Tocotrienols in Cerebral and Myocardial Ischemia-Reperfusion Injury: A Systematic Review
by: Fitri Fareez Ramli, et al.
Published: (2021-08-01)

Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol
by: Fabrizio Fontana, et al.
Published: (2022-05-01)

Effects of tocotrienol supplementation on platelet aggregation in subjects with metabolic syndrome
by: Gan, Yee Lin
Published: (2014)

Food for Bone: Evidence for a Role for Delta-Tocotrienol in the Physiological Control of Osteoblast Migration
by: Lavinia Casati, et al.
Published: (2020-06-01)

STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel
by: Sandra M. Rocha, et al.
Published: (2023-04-01)

Alpha-tocotrienol as a possible indicator for monitoring the presence of palm mid-fraction in dark chocolate
by: Farahany, Elham Moazami
Published: (2006)

A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients
by: Michael B. Lilly, et al.
Published: (2024-03-01)

Oligo(Lactic Acid)<sub>8</sub>-Docetaxel Prodrug-Loaded PEG-<i>b</i>-PLA Micelles for Prostate Cancer
by: Lauren Repp, et al.
Published: (2021-10-01)

A Novel Docetaxel-Biotin Chemical Conjugate for Prostate Cancer Treatment
by: Mahmoud Rayan, et al.
Published: (2022-01-01)

POSSIBILITIES OF A COMBINATION OF DOCETAXEL WITH ANDROGEN DEPRIVATION IN INITIAL THERAPY OF HORMONESENSITIVE PROSTATE CANCER
by: A. A. GRITSKEVICH, et al.
Published: (2017-06-01)

Caspase-Linked Programmed Cell Death in Prostate Cancer: From Apoptosis, Necroptosis, and Pyroptosis to PANoptosis
by: Minggang Zhu, et al.
Published: (2023-11-01)

Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
by: Mingyue Xia, et al.
Published: (2022-11-01)

The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
by: Bisheng Cheng, et al.
Published: (2023-11-01)

The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells
by: Reem T. Attia, et al.
Published: (2016-06-01)

The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant Prostate Cancer Cells
by: Greisha L. Ortiz-Hernandez, et al.
Published: (2021-10-01)

Corrigendum: Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
by: Mingyue Xia, et al.
Published: (2023-07-01)

Neutropenia and docetaxel exposure in metastatic castration‐resistant prostate cancer patients: A meta‐analysis and evaluation of a clinical cohort
by: Aurelia H. M. deVries Schultink, et al.
Published: (2019-04-01)